Combined Radiochemotherapy with Paclitaxel in the Treatment of Malignant Glioma

[1]  A. Nirenberg,et al.  Phase II Study of Combination Taxol and Estramustine Phosphate in the Treatment of Recurrent Glioblastoma Multiforme , 2000, Journal of Neuro-Oncology.

[2]  K. Walter,et al.  Cytotoxicity of taxol in vitro against human and rat malignant brain tumors , 2004, Cancer Chemotherapy and Pharmacology.

[3]  A. Siegmann,et al.  Acute Toxicity and Changes in Quality of Life during a Combined Radio-Chemotherapy of Glioblastomas with Topotecan (Hycamtin®) , 2001, Strahlentherapie und Onkologie.

[4]  P. Herschbach,et al.  Krankheitsspezifische Belastungen von Tumorpatienten zu Beginn einer Strahlentherapie Auswirkungen auf den psychosozialen Betreuungsbedarf , 2001, Strahlentherapie und Onkologie.

[5]  H. Aydin,et al.  Patterns of Failure Following CT-Based 3-D Irradiation for Malignant Glioma , 2001, Strahlentherapie und Onkologie.

[6]  M. Hulshof,et al.  Prognostic Factors in Glioblastoma Multiforme 10 Years Experience of a Single Institution , 2001, Strahlentherapie und Onkologie.

[7]  Gerhard H. Schlund,et al.  Anforderungen an die Patientenaufklärung am Beispiel der Strahlentherapie , 2001, Strahlentherapie und Onkologie.

[8]  Susan M. Chang,et al.  A Phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants , 2001, Cancer.

[9]  H. Dubben,et al.  Der Fehler zweiter Art und seine Bedeutung bei der Beurteilung von Resultaten Qualitätsanalyse der Zeitschrift “Strahlentherapie und Onkologie” , 2000, Strahlentherapie und Onkologie.

[10]  W. Geerts,et al.  The risk of venous thromboembolism is increased throughout the course of malignant glioma , 2000, Cancer.

[11]  U. Nestle,et al.  A Review of Current and Future Treatment Strategies for Malignant Astrocytomas in Adults , 2000, Strahlentherapie und Onkologie.

[12]  L. Beenen,et al.  A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade glioma. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  P. Julka,et al.  A study of concurrent radiochemotherapy with paclitaxel in glioblastoma multiforme. , 2000, Australasian radiology.

[14]  L. Hu,et al.  Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation. , 1997, International journal of radiation oncology, biology, physics.

[15]  M. Berger,et al.  Phase II study of paclitaxel in patients with recurrent malignant glioma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  H. Choy,et al.  Weekly, outpatient paclitaxel and concurrent cranial irradiation in adults with brain tumors: preliminary results and promising directions. , 1995, Seminars in Oncology.

[17]  M. Chamberlain,et al.  Salvage chemotherapy with paclitaxel for recurrent primary brain tumors. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  H. Choy,et al.  Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors. , 1995, Journal of the National Cancer Institute.

[19]  L. Peters,et al.  Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse. , 1995, Acta oncologica.

[20]  M. Taphoorn,et al.  Paclitaxel (Taxol) concentrations in brain tumor tissue. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  E. Hall,et al.  Taxol and ionizing radiation: interaction and mechanisms. , 1994, International journal of radiation oncology, biology, physics.

[22]  E. Hall,et al.  Taxol sensitizes human astrocytoma cells to radiation. , 1992, Cancer research.

[23]  G. Sheline,et al.  Radiotherapy for high grade gliomas. , 1990, International journal of radiation oncology, biology, physics.

[24]  S B Green,et al.  Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. , 1989, Journal of neurosurgery.

[25]  D. Nelson,et al.  A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study. , 1983, International journal of radiation oncology, biology, physics.

[26]  Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind study. , 1983, European journal of cancer & clinical oncology.

[27]  D P Byar,et al.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. , 1980, The New England journal of medicine.

[28]  P. Band,et al.  Radiation and high-dose metronidazole in supratentorial glioblastomas. , 1976, The New England journal of medicine.